Imran Hamid, MD

Imran Hamid, MD has a diverse work experience in the healthcare and investment sectors. Imran currently holds the role of Senior Investment Principal at LifeArc Ventures, where they focus on investing in innovative therapeutics and healthtech companies. Prior to this, they served as an Investor Director at Stealth Digital HealthTech, Surgery Hero, ikarovec, and Cumulus Neuroscience, where they played a crucial role in scaling and supporting these companies. Earlier in their career, they also served as a Board Observer at Closed Loop Medicine and DJS Antibodies, which was later acquired by AbbVie. Before transitioning into the investment field, Dr. Hamid held senior leadership roles at Johnson & Johnson and Mallinckrodt Pharmaceuticals, where they drove innovation and business development initiatives. At MSD, they led the Commercial Discovery team and spearheaded collaborations with the NHS and strategic commercial partners to develop novel pharmaceutical and digital health solutions. Overall, Dr. Hamid's work experience showcases their expertise in investment, business development, and driving innovation in the healthcare industry.

Imran Hamid, MD has a diverse educational background. From 1999 to 2005, they attended Imperial College London where they earned an MBBS BSc (Hons) degree in Medicine and Healthcare Management. In 2003 and 2004, Imran enrolled in Imperial College Business School, completing a BSc (Hons) degree in Management. In 2007, they studied at The Royal College of Surgeons of England, specializing in Surgery and obtaining an MRCS degree. Additionally, Imran attended St Paul's School from 1994 to 1999, although there is no information available regarding the degree or field of study during that period.